
Repeat dosing of 60 mg AB-729 every 8 weeks resulted in mean HBsAg declines of –1.37 log10 (N=6) comparable to AB-729 dosed every 4 weeks (–1.44 log10, N=7, p
On 6ix: 6ix.com/news/arbutus-announces-robust-hbsag-decline-data-with-ab-729-dosed-at-60-mg-every-8-weeks

Repeat dosing of 60 mg AB-729 every 8 weeks resulted in mean HBsAg declines of –1.37 log10 (N=6) comparable to AB-729 dosed every 4 weeks (–1.44 log10, N=7, p
Arbutus Biopharma Corporation on 6ix
Follow Arbutus Biopharma into a list and get an email when it puts out news.
Follow Arbutus Biopharma